Updated 01:14 AM PHT Wed, December 30, 2015
Iloilo City (CNN Philippines) — Vaccines which can prevent four types of dengue will be available nationwide in the first quarter of 2016.
Director Marlyn Convocar of the Department of Health (DOH-6) made the announcement on Monday (December 28) and said Dengvaxia had passed the test conducted by the Food and Drug Administration (FDA).
Last week, Health Secretary Janette Garin approved the registration of of the vaccine manufactured by Sanofi Pasteur.
Convocar added there were no guidelines yet from DOH as to the price of the vaccine but it could be included in PhilHealth.
"There will always be special prices for those under the National Household Targeting System for Poverty Reduction (NHTS-PR), the marginalized, and the poorest of the poor," she said.
Persons 9 to 45 years old will be prioritized once the vaccine is available in the market.
The vaccine has an effectivity rate of 80 percent.